Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer
0.50 hr(s) | ABIM , CME , MOC , NCPD
Specialty: Endometrial Cancer , Gynecologic Cancer , Oncology
Therapeutic Area(s): Endometrial Cancer , Gynecology , Oncology
Release Date: April 27, 2022
Expiration Date: April 26, 2023
Location: Internet Enduring Activity
In this activity, an expert in oncology discusses the role of immune checkpoint inhibitors in the care of patients with recurrent and advanced endometrial cancer.